Abstract
ABSTRACT Why have Russia and Cuba developed and produced vaccines against COVID-19 while Central and Eastern European (CEE) countries that are members of the European Union have only played a marginal role in the global supply of such vaccines? We argue that the answer is to be found in the capacity of Russia’s national security state and entrepreneurs to mobilise historic Soviet advantages as part of a broader security motivated statecraft. CEE countries lacked this legacy and this drive. Similarly, they failed to massively invest – as for example, Cuba has – into potential synergies between public health systems and biotech firms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
